- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
oversold the past few months, will grow a bit back. Good pick for short-term growth
Recs
Yes, Stock undervalued.
Recs
They sell pain relievers that i need for my backaches.
Recs
Under value.
Recs
Horizon is the next big pharma.
Recs
Ramping up sales force. New drugs in the pipeline. Extremely large insider purchase by Jeffrey Bird ($2mm @ $3.49) plus instituions have snapped up shares to make up >20% of float. Short interest is extremely high on this stock, so hopefully a short squeeze could put it up over $4 by year-end.
Recs
THEY ARE CREATING NEW HEALTH TECHNOLOGIES TO MAKE HEALTHCARE AND HEALTH SENSORS MORE ACCESSIBLE TO THE MASSES.
Recs
1) Insiders are in over $9.
2) Their drug is marketed overseas.
3) # of shares outstanding is relatively small.
4) recently went public.
5) PDUFA
Recs
PDUFA coming up
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 9 of 9